Immune-related adverse events: what we've learned and where we're heading. Issue 9 (1st September 2020)
- Record Type:
- Journal Article
- Title:
- Immune-related adverse events: what we've learned and where we're heading. Issue 9 (1st September 2020)
- Main Title:
- Immune-related adverse events: what we've learned and where we're heading
- Authors:
- Badran, Yousef R.
Leet, Donna E.
Dougan, Michael - Abstract:
- Is Part Of:
- Expert review of anticancer therapy. Volume 20:Issue 9(2020)
- Journal:
- Expert review of anticancer therapy
- Issue:
- Volume 20:Issue 9(2020)
- Issue Display:
- Volume 20, Issue 9 (2020)
- Year:
- 2020
- Volume:
- 20
- Issue:
- 9
- Issue Sort Value:
- 2020-0020-0009-0000
- Page Start:
- 727
- Page End:
- 730
- Publication Date:
- 2020-09-01
- Subjects:
- TNFα -- corticosteroids -- PD-1 -- CTLA-4 -- immune-checkpoint inhibitor -- immune-related adverse event -- infliximab -- vedolizumab
Cancer -- Treatment -- Periodicals
616.99406 - Journal URLs:
- http://informahealthcare.com ↗
http://www.future-drugs.com/loi/era ↗ - DOI:
- 10.1080/14737140.2020.1803742 ↗
- Languages:
- English
- ISSNs:
- 1473-7140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002982
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 22527.xml